The purpose of the present invention is to provide a therapeutic or prophylactic agent for multiple sclerosis, which contains a non-steroid low-molecular-weight compound as an active ingredient. The present invention provides a therapeutic or prophylactic agent for multiple sclerosis, which contains a cyclohexane derivative typified by a compound shown below or a pharmacologically acceptable salt thereof as an active ingredient.